Ebtesam Abdalla

Prof. Dr. Ebtesam Abdalla

Alexandria University, Alexandria, Al Iskandarīyah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2020 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
HSHanan E. Shamseldin
Hanan E. Shamseldin
RSRanad Shaheen
Ranad Shaheen
NENour Ewida
Nour Ewida
DBDalal K. Bubshait
Dalal K. Bubshait
HAHisham Alkuraya
Hisham Alkuraya
FAFowzan S. Alkuraya
Fowzan S. Alkuraya

1 September 2018 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
IIIvan Ivanovski
Ivan Ivanovski
ODOlivera Djuric
Olivera Djuric
SCStefano Giuseppe Caraffi
Stefano Giuseppe Caraffi
DSDaniela Santodirocco
Daniela Santodirocco
MPMarzia Pollazzon
Marzia Pollazzon
LGLivia Garavelli
Livia Garavelli
Mowat–Wilson syndrome (MWS) is a rare intellectual disability/multiple congenital anomalies syndrome caused by heterozygous mutation of the ZEB2 gene. It is generally underestimated because its rarity and phenotypic variability sometimes make it difficult to recognize. Here, we aimed to better delineate the phenotype, natural history, and genotype–phenotype correlations of MWS. In a collaborative study, we analyzed clinical data for 87 patients with molecularly confirmed diagnosis. We described the prevalence of all clinical aspects, including attainment of neurodevelopmental milestones, and compared the data with the various types of underlying ZEB2 pathogenic variations. All anthropometric, somatic, and behavioral features reported here outline a variable but highly consistent phenotype. By presenting the most comprehensive evaluation of MWS to date, we define its clinical evolution occurring with age and derive suggestions for patient management. Furthermore, we observe that its severity correlates with the kind of ZEB2 variation involved, ranging from ZEB2 locus deletions, associated with severe phenotypes, to rare nonmissense intragenic mutations predicted to preserve some ZEB2 protein functionality, accompanying milder clinical presentations. Knowledge of the phenotypic spectrum of MWS and its correlation with the genotype will improve its detection rate and the prediction of its features, thus improving patient care.

1 January 2012 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
EKErsan Kalay
Ersan Kalay
OSOrhan Sezgin
Orhan Sezgin
VCVasant Chellappa
Vasant Chellappa
MMMehmet Mutlu
Mehmet Mutlu
HMHeba Morsy
Heba Morsy
NANurten A. Akarsu
Nurten A. Akarsu

17 July 2014 in Human Mutation
Verified
Journal Article
Closed access
PDF file
PMPeriklis Makrythanasis
Periklis Makrythanasis
MNMari Nelis
Mari Nelis
FSFederico A. Santoni
Federico A. Santoni
MGMichel Guipponi
Michel Guipponi
AVAnne Vannier
Anne Vannier
SAStylianos E. Antonarakis
Stylianos E. Antonarakis
Rare, atypical, and undiagnosed autosomal‐recessive disorders frequently occur in the offspring of consanguineous couples. Current routine diagnostic genetic tests fail to establish a diagnosis in many cases. We employed exome sequencing to identify the underlying molecular defects in patients with unresolved but putatively autosomal‐recessive disorders in consanguineous families and postulated that the pathogenic variants would reside within homozygous regions. Fifty consanguineous families participated in the study, with a wide spectrum of clinical phenotypes suggestive of autosomal‐recessive inheritance, but with no definitive molecular diagnosis. DNA samples from the patient(s), unaffected sibling(s), and the parents were genotyped with a 720K SNP array. Exome sequencing and array CGH (comparative genomic hybridization) were then performed on one affected individual per family. High‐confidence pathogenic variants were found in homozygosity in known disease‐causing genes in 18 families (36%) (one by array CGH and 17 by exome sequencing), accounting for the clinical phenotype in whole or in part. In the remainder of the families, no causative variant in a known pathogenic gene was identified. Our study shows that exome sequencing, in addition to being a powerful diagnostic tool, promises to rapidly expand our knowledge of rare genetic Mendelian disorders and can be used to establish more detailed causative links between mutant genotypes and clinical phenotypes.

1 June 2017 in Genetics in Medicine
Verified
Journal Article
Open access
LGLivia Garavelli
Livia Garavelli
IIIvan Ivanovski
Ivan Ivanovski
SCStefano Giuseppe Caraffi
Stefano Giuseppe Caraffi
DSDaniela Santodirocco
Daniela Santodirocco
MPMarzia Pollazzon
Marzia Pollazzon
APAlex R Paciorkowski
Alex R Paciorkowski
Mowat-Wilson syndrome (MWS) is a genetic disease characterized by distinctive facial features, moderate to severe intellectual disability, and congenital malformations, including Hirschsprung disease, genital and eye anomalies, and congenital heart defects, caused by haploinsufficiency of the ZEB2 gene. To date, no characteristic pattern of brain dysmorphology in MWS has been defined. Through brain magnetic resonance imaging (MRI) analysis, we delineated a neuroimaging phenotype in 54 MWS patients with a proven ZEB2 defect, compared it with the features identified in a thorough review of published cases, and evaluated genotype-phenotype correlations. Ninety-six percent of patients had abnormal MRI results. The most common features were anomalies of corpus callosum (79.6% of cases), hippocampal abnormalities (77.8%), enlargement of cerebral ventricles (68.5%), and white matter abnormalities (reduction of thickness 40.7%, localized signal alterations 22.2%). Other consistent findings were large basal ganglia, cortical, and cerebellar malformations. Most features were underrepresented in the literature. We also found ZEB2 variations leading to synthesis of a defective protein to be favorable for psychomotor development and some epilepsy features but also associated with corpus callosum agenesis. This study delineated the spectrum of brain anomalies in MWS and provided new insights into the role of ZEB2 in neurodevelopment.Genet Med advance online publication 10 November 2016.

Verified
Journal Article
Open access
PDF file
Luigi DonatoLuigi Donato
Luigi Donato
Concetta ScimoneConcetta Scimone
Concetta Scimone
SASimona alibrandi
Simona alibrandi
EAEbtesam Abdalla
Ebtesam Abdalla
KNKarim Mahmoud Nabil
Karim Mahmoud Nabil
Antonina SidotiAntonina Sidoti
Antonina Sidoti
Ion channels are membrane-spanning integral proteins expressed in multiple organs, including the eye. Here, ion channels play a role in several physiological processes, like signal transmission and visual processing. A wide range of mutations have been reported in the corresponding genes and their interacting subunit coding genes, which contribute significantly to a wide spectrum of ocular diseases collectively called channelopathies, a subgroup of inherited retinal dystrophies. Such mutations result in either a loss or gain-of channel functions affecting the structure, assembly, trafficking and localization of channel proteins. We investigated the probands of seven Italian and Egyptian families affected by not completely defined forms of inherited retinal dystrophies, by whole exome sequencing (WES) experiments, and found interesting variants in already known causative genes probably able to impair retinal functionalities. However, because such variants did not completely explain the phenotype manifested by each patient, we proceed to further investigate possible related genes carrying mutations that might complement previously found data, based on the common aspect linked to neurotransmission impairments. We found 10 mutated genes whose variants might alter important ligand binding sites differently distributed through all considered patients. Such genes encode for ion channels, or their regulatory proteins, and strictly interact with known causative genes, also sharing with them synaptic-related pathways. Taking into account several limitations that will be resolved by further experiments, we believe that our exploratory investigation will help scientists to provide a new promising paradigm for precise diagnosis of retinal dystrophies to facilitate the development of rational treatments.